ReviewGastro hep advances2025

Anti-Integrin αvβ6 Antibody Titer as a Predictive Biomarker of Future Treatment Escalation in Patients With Ulcerative Colitis.

Shuji Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.